Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate L Weeks

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Cellular Signalling|December 13, 2021
Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunitiesNicola M Sergienko, Daniel G Donner, Lea M D Delbridge, et al.
Archives of Toxicology|February 25, 2015
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targetsYow Keat Tham, Bianca C Bernardo, Jenny Y Y Ooi, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 27, 2019
CORP: Practical tools for improving experimental design and reporting of laboratory studies of cardiovascular physiology and metabolismKate L Weeks, Darren C Henstridge, Agus Salim, et al.
Journal of Visualized Experiments : Jove|December 27, 2021
A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based AssaySebastian Bass-Stringer, Colleen J Thomas, Clive N May, et al.
Heart, Lung & Circulation|April 29, 2018
Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart FailureSebastian Bass-Stringer, Bianca C Bernardo, Clive N May, et al.
Cells|May 13, 2023
Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer TherapySanela Dozic, Erin J Howden, James R Bell, et al.
Journal of Molecular and Cellular Cardiology Plus|June 9, 2025
PP2A-B56α is a key determinant of cardiac protein phosphorylation and functional responses to β-adrenergic signallingAlican Güran, Yanlong Ji, Pan Fang, et al.
Cardiovascular Research|September 12, 2018
Role of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivoSarah-Lena Puhl, Kate L Weeks, Alican Güran, et al.
Heart, Lung & Circulation|May 14, 2025
Lipidomic Profiling of a Preclinical Model of Streptozotocin-Induced Diabetic Cardiomyopathy Reveals Potential Plasma BiomarkersBianca C Bernardo, Alexandra N Faulkner, Tingting Wang, et al.
Journal of the American Heart Association|March 27, 2017
β-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α-PP2A-Mediated DephosphorylationKate L Weeks, Antonella Ranieri, Agnieszka Karaś, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Cellular Signalling|December 13, 2021
Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunitiesNicola M Sergienko, Daniel G Donner, Lea M D Delbridge, et al.
Archives of Toxicology|February 25, 2015
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targetsYow Keat Tham, Bianca C Bernardo, Jenny Y Y Ooi, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 27, 2019
CORP: Practical tools for improving experimental design and reporting of laboratory studies of cardiovascular physiology and metabolismKate L Weeks, Darren C Henstridge, Agus Salim, et al.
Journal of Visualized Experiments : Jove|December 27, 2021
A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based AssaySebastian Bass-Stringer, Colleen J Thomas, Clive N May, et al.
Heart, Lung & Circulation|April 29, 2018
Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart FailureSebastian Bass-Stringer, Bianca C Bernardo, Clive N May, et al.
Cells|May 13, 2023
Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer TherapySanela Dozic, Erin J Howden, James R Bell, et al.
Journal of Molecular and Cellular Cardiology Plus|June 9, 2025
PP2A-B56α is a key determinant of cardiac protein phosphorylation and functional responses to β-adrenergic signallingAlican Güran, Yanlong Ji, Pan Fang, et al.
Cardiovascular Research|September 12, 2018
Role of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivoSarah-Lena Puhl, Kate L Weeks, Alican Güran, et al.
Heart, Lung & Circulation|May 14, 2025
Lipidomic Profiling of a Preclinical Model of Streptozotocin-Induced Diabetic Cardiomyopathy Reveals Potential Plasma BiomarkersBianca C Bernardo, Alexandra N Faulkner, Tingting Wang, et al.
Journal of the American Heart Association|March 27, 2017
β-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α-PP2A-Mediated DephosphorylationKate L Weeks, Antonella Ranieri, Agnieszka Karaś, et al.
Pageof 6